Pijl A J, Pfaffendorf M, van Zwieten P A
Department of Pharmacotherapy, Academic Medical Centre, Amsterdam, The Netherlands.
J Cardiovasc Pharmacol. 1993 Sep;22(3):381-7. doi: 10.1097/00005344-199309000-00006.
We compared two newer dihydropyridine-calcium antagonists (lacidipine and nisoldipine) with the classic prototype of this group, nifedipine, in the rat working heart preparation. The hearts were paced at a frequency of 5 Hz and perfused with Tyrode's solution of 37 degrees C. The following five parameters were determined: left ventricular pressure (LVP), maximal rate of pressure increase (+dP/dtmax), aortic output (AO), coronary blood flow (CBF), and cardiac output (CO). First, dose-response curves were constructed; from these data the EC50 concentration for the three calcium antagonists was calculated. Subsequently, washout from the cardiac tissue for these three compounds was determined. The effects of lacidipine did not diminish during < or = 90-min washout, whereas the effects of nifedipine disappeared completely in 10 min. The effects of nisoldipine, however, disappeared partly in 10 min. In separate experiments, the antiischemic activity of the three calcium antagonists was analyzed, using low-flow ischemia. The calcium antagonists were used in a concentration that produced a 60% reduction in contractile force (EC60). Nifedipine and nisoldipine caused significant improvement in functional recovery. The antiischemic properties of lacidipine could not be shown because of its slow kinetic properties with accumulation in the membrane phase and slow kinetics with the channel. Nisoldipine and lacidipine appear to be more potent calcium antagonists as compared with nifedipine, whereas lacidipine displays a clearly different kinetic pattern in comparison to nifedipine and nisoldipine. In particular, the extremely slow onset and very long duration of action of lacidipine are of interest.
我们在大鼠工作心脏制备模型中,将两种新型二氢吡啶类钙拮抗剂(拉西地平与尼索地平)与该类药物的经典原型硝苯地平进行了比较。心脏以5赫兹的频率起搏,并用37摄氏度的台氏液灌注。测定了以下五个参数:左心室压力(LVP)、最大压力上升速率(+dP/dtmax)、主动脉输出量(AO)、冠状动脉血流量(CBF)和心输出量(CO)。首先,构建剂量-反应曲线;根据这些数据计算出三种钙拮抗剂的半数有效浓度(EC50)。随后,测定这三种化合物在心脏组织中的洗脱情况。拉西地平在洗脱时间≤90分钟时作用未减弱,而硝苯地平的作用在10分钟内完全消失。然而,尼索地平的作用在10分钟内部分消失。在单独的实验中,采用低流量缺血法分析了三种钙拮抗剂的抗缺血活性。所用钙拮抗剂的浓度能使收缩力降低60%(EC60)。硝苯地平和尼索地平使功能恢复有显著改善。由于拉西地平在膜相蓄积的动力学性质缓慢且与通道相关的动力学也缓慢,其抗缺血特性未能显示出来。与硝苯地平相比,尼索地平和拉西地平似乎是更有效的钙拮抗剂,而拉西地平与硝苯地平和尼索地平相比表现出明显不同的动力学模式。特别是,拉西地平起效极慢且作用持续时间极长,这一点很有意思。